Complaint·October 31, 2025

Review of R1’s Medication Administration Record (MAR) from February 2025 through October 2025 revealed no gaps or missed doses related to rash or scabies medications. During two separate unannounced visits on 07/29/2025 and 10/27/2025, LPA Lee reviewed medications for R1, and did not observe any deficiencies. Interviews were conducted with seven residents, all of whom stated they had no concerns regarding staff obtaining timely medical care, and their medications being administered. R1 also confirmed that they receive their prescribed medications and apply their rash medication independently and have no concerns about their medications. Interviews with five facility staff also stated that medications are administered to residents as well as residents’ rash medications. Interview with R1's responsible party (RP) also stated no concerns with the allegations. An interview with an outside agency confirmed that skin scraping is the proper way to diagnose scabies and noted that R1 did not undergo this procedure. The outside agency also explained that emergency departments often prescribe similar medications for both rash and scabies as a precaution. Based on the records review and statements conducted during the investigation process LPA Lee was unable to corroborate the allegation that staff did not obtain timely medical care for a resident and that staff are not following physician’s orders. The investigation revealed the preponderance of evidence standards has not been met; therefore, the above allegations is found to be UNSUBSTANTIATED. A finding that the complaint allegations are unsubstantiated means that although the allegations may have happened or is valid, there is not a preponderance of the evidence to prove that the alleged violations occurred. An exit interview was conducted with Executive Director Corpus, and a copy of this report was provided to the facility.